{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T01:47:04Z","timestamp":1774921624353,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1995,4]]},"DOI":"10.1378\/chest.107.4.1018","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T22:31:17Z","timestamp":1201041077000},"page":"1018-1023","source":"Crossref","is-referenced-by-count":19,"title":["The Impact of Prophylaxis on Outcome and Resource Utilization in Pneumocystis carinii Pneumonia"],"prefix":"10.1016","volume":"107","author":[{"given":"Joel E.","family":"Gallant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon M.","family":"McAvinue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Chaisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.107.4.1018_bib1","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.259.8.1185","article-title":"Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS","volume":"259","author":"Fischl","year":"1988","journal-title":"JAMA"},{"key":"10.1378\/chest.107.4.1018_bib2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-120-11-199406010-00006","article-title":"Prophylaxis for opportunistic infections in patients with HIV infection","volume":"120","author":"Gallant","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.107.4.1018_bib3","first-page":"46","article-title":"Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus","volume":"6","year":"1993","journal-title":"J Acquir Immun Defic Syndr"},{"key":"10.1378\/chest.107.4.1018_bib4","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/archinte.1992.00400220041007","article-title":"Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine","volume":"152","author":"Chaisson","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.107.4.1018_bib5","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJM199204163261601","article-title":"The effects on survival of early treatment of human immunodeficiency virus infection","volume":"326","author":"Graham","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.4.1018_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0140-6736(91)90414-K","article-title":"Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS: the Multicenter AIDS Cohort Study","volume":"338","author":"Graham","year":"1991","journal-title":"Lancet"},{"key":"10.1378\/chest.107.4.1018_bib7","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJM199212243272606","article-title":"Prevention and treatment of Pneumocystis pneumonia","volume":"327","author":"Masur","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.4.1018_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM199009203231201","article-title":"Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia: the San Francisco Community Prophylaxis Trial","volume":"323","author":"Leoung","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.4.1018_bib9","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199212243272604","article-title":"A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: AIDS Clinical Trials Group protocol 021","volume":"327","author":"Hardy","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.4.1018_bib10","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJM199212243272603","article-title":"A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection","volume":"327","author":"Schneider","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.4.1018_bib11","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1128\/JCM.28.10.2228-2233.1990","article-title":"Rapid detection of Pneumocystis carinii using a direct fluorescent monoclonal antibody stain","volume":"28","author":"Ng","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1378\/chest.107.4.1018_bib12","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jama.1991.03470080088036","article-title":"The Maryland experience and a practical proposal to expand existing models in ambulatory primary care","volume":"266","author":"Riley","year":"1991","journal-title":"JAMA"},{"key":"10.1378\/chest.107.4.1018_bib13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/jama.1991.03470060082031","article-title":"Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia","volume":"266","author":"Castellano","year":"1991","journal-title":"JAMA"},{"key":"10.1378\/chest.107.4.1018_bib14","first-page":"831","article-title":"The effects of intravenous drug use and gender on cost of hospitalization for patients with AIDS","volume":"6","author":"Seage GR","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1378\/chest.107.4.1018_bib15","series-title":"AIDS in California: expenditures, demographics, and mortality for persons with AIDS on Medi-Cal","author":"Kizer","year":"1988"},{"key":"10.1378\/chest.107.4.1018_bib16","first-page":"856","article-title":"Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987","volume":"5","author":"Bennett","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1378\/chest.107.4.1018_bib17","first-page":"1","article-title":"HIV prevalence estimates and AIDS case projections for the United States: report based upon a workshop","volume":"39","year":"1990","journal-title":"MMWR"},{"key":"10.1378\/chest.107.4.1018_bib18","first-page":"110","article-title":"Estimate of HIV prevalence and projected AIDS cases: summary of a workshop, October 31-November 1, 1989","volume":"96","year":"1990","journal-title":"MMWR"},{"key":"10.1378\/chest.107.4.1018_bib19","first-page":"137","article-title":"Publicly funded HIV counseling and testing\u2014United States, 1985\u20131989","volume":"39","year":"1990","journal-title":"MMWR"},{"key":"10.1378\/chest.107.4.1018_bib20","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM198905113201905","article-title":"The case for wider use of testing for HIV infection","volume":"320","author":"Rhame","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.4.1018_bib21","series-title":"AIDS and intravenous drug abuse among minorities","year":"1989"},{"key":"10.1378\/chest.107.4.1018_bib22","first-page":"249","article-title":"AIDS statistics and the risk for minorities","volume":"2","author":"Bakeman","year":"1986","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1378\/chest.107.4.1018_bib23","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1001\/jama.1989.03420180101039","article-title":"Prevalence of HIV infection among intravenous drug users in the United States","volume":"261","author":"Hahn","year":"1989","journal-title":"JAMA"},{"key":"10.1378\/chest.107.4.1018_bib24","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1001\/jama.1989.03420160030008","article-title":"Leads from the MMWR: acquired immunodeficiency syndrome associated with intravenous drug use\u2014the United States, 1988","volume":"261","year":"1989","journal-title":"JAMA"},{"key":"10.1378\/chest.107.4.1018_bib25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1126\/science.3340847","article-title":"Epidemiology of HIV infection and AIDS in the United States","volume":"239","author":"Curran","year":"1988","journal-title":"Science"},{"key":"10.1378\/chest.107.4.1018_bib26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.1990.03450100051024","article-title":"The \u2018medicaidization\u2019 of AIDS","volume":"264","author":"Green","year":"1990","journal-title":"JAMA"},{"key":"10.1378\/chest.107.4.1018_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1377\/hlthaff.7.4.32","article-title":"The economic impact of AIDS in the United States","volume":"7","author":"Scitovsky","year":"1988","journal-title":"Health Aff"},{"key":"10.1378\/chest.107.4.1018_bib28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/jama.1987.03400100077024","article-title":"The provision and financing of medical care for AIDS patients in US public and private teaching hospitals","volume":"258","author":"Andrulis","year":"1987","journal-title":"JAMA"},{"key":"10.1378\/chest.107.4.1018_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM198707163170333","article-title":"Financing the struggle against AIDS","volume":"317","author":"Iglehart","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.4.1018_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM199403173301107","article-title":"Racial differences in the use of drug therapy for HIV disease in an urban community","volume":"330","author":"Moore","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.4.1018_bib31","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1001\/jama.1991.03470190061030","article-title":"Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease","volume":"266","author":"Easterbrook","year":"1991","journal-title":"JAMA"},{"key":"10.1378\/chest.107.4.1018_bib32","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199105163242006","article-title":"Zidovudine and the natural history of the acquired immunodeficiency syndrome","volume":"324","author":"Moore","year":"1991","journal-title":"N Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216332196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216332196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T03:21:28Z","timestamp":1588303288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216332196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["S0012369216332196"],"URL":"https:\/\/doi.org\/10.1378\/chest.107.4.1018","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}